A Phase II, Randomized, Double-blind, Placebo-controlled study to examine the effects of DAS181 in immunocompromised subjects with Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Project: Research project

Project Details

StatusActive
Effective start/end date12/1/148/31/50

Funding

  • Ansun Biopharma, Inc.